+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

IDWeek 2026: Pre-Conference Coverage - Product Thumbnail Image

IDWeek 2026: Pre-Conference Coverage

  • Report
  • October 2026
  • 14 Pages
  • Global
From
From
From
Congestive Heart Failure (Heart Failure) - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Congestive Heart Failure (Heart Failure) - Global Clinical Trials Review, 2026

  • Clinical Trials
  • September 2026
  • 3158 Pages
  • Global
From
Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2026

  • Clinical Trials
  • September 2026
  • 205 Pages
  • Global
From
Friedreich Ataxia - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Friedreich Ataxia - Global Clinical Trials Review, 2026

  • Clinical Trials
  • September 2026
  • 119 Pages
  • Global
From
From
Narcolepsy: Epidemiology Forecast to 2035 - Product Thumbnail Image

Narcolepsy: Epidemiology Forecast to 2035

  • Report
  • September 2026
  • 35 Pages
  • Global
From
Narcolepsy: Seven-Market Drug Forecast and Market Analysis 2025-35 - Product Thumbnail Image

Narcolepsy: Seven-Market Drug Forecast and Market Analysis 2025-35

  • Report
  • September 2026
  • 96 Pages
  • Global
From
Dementia - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Dementia - Global Clinical Trials Review, 2026

  • Clinical Trials
  • August 2026
  • 1099 Pages
  • Global
From
Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2026

  • Clinical Trials
  • August 2026
  • 321 Pages
  • Global
From
Spinal Muscular Atrophy (SMA) - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Spinal Muscular Atrophy (SMA) - Global Clinical Trials Review, 2026

  • Clinical Trials
  • August 2026
  • 191 Pages
  • Global
From
From
Major Depressive Disorder: Epidemiology Report and Forecast - Product Thumbnail Image

Major Depressive Disorder: Epidemiology Report and Forecast

  • Report
  • August 2026
  • 46 Pages
  • Global
From
Type 2 Diabetes (T2D): Epidemiology Report and Forecast - Product Thumbnail Image

Type 2 Diabetes (T2D): Epidemiology Report and Forecast

  • Report
  • July 2026
  • 56 Pages
  • Global
From
Psoriasis - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Psoriasis - Global Clinical Trials Review, 2026

  • Clinical Trials
  • July 2026
  • 2247 Pages
  • Global
From
Inflammatory Bowel Disease - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Inflammatory Bowel Disease - Global Clinical Trials Review, 2026

  • Clinical Trials
  • July 2026
  • 3257 Pages
  • Global
From
Vertigo - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Vertigo - Global Clinical Trials Review, 2026

  • Clinical Trials
  • July 2026
  • 171 Pages
  • Global
From
From
Focal Segmental Glomerulosclerosis (FSGS): Market View - Product Thumbnail Image

Focal Segmental Glomerulosclerosis (FSGS): Market View

  • Report
  • July 2026
  • 77 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more